lipoprotein(a) fasting state
Selected indexed studies
- Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial. (JAMA, 2023) [PMID:37952254]
- Lipid Profile and Lipoprotein(a) Testing. (Dtsch Arztebl Int, 2023) [PMID:37403458]
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. (Eur Heart J, 2016) [PMID:27122601]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. (2016) pubmed
- Lipid Profile and Lipoprotein(a) Testing. (2023) pubmed
- Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial. (2023) pubmed
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. (2016) pubmed
- Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl. (2024) pubmed
- Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk. (2014) pubmed
- A Test in Context: Lipid Profile, Fasting Versus Nonfasting. (2017) pubmed
- A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome. (2022) pubmed
- Pediatric Dyslipidemia-Beyond Familial Hypercholesterolemia. (2020) pubmed
- Serum Lipoprotein(a) Is Not Associated with Graves' Ophthalmopathy. (2024) pubmed